ABCSG 34 Summary
A prospective, open, randomized, phase-II-study of a therapeutic cancer vaccine (L-BLP25, Tecemotide) in the pre-operative treatment of women with primary breast cancer.
|Coordinating investigator:||Gnant, Michael; Vienna |
Singer, Christian; Vienna
(Click to enlare)
Link for studyteam-members only
Further information about this trial
Access to these informations only with keyword. If required, please ask the responsible project manager.